Advanced Light Source Analytical Techniques for Exploring the Biological Behavior and Fate of Nanomedicines

被引:16
|
作者
Cao, Mingjing [1 ,2 ]
Zhang, Kai [3 ]
Zhang, Shuhan [1 ,2 ]
Wang, Yaling [1 ,2 ,4 ]
Chen, Chunying [1 ,2 ,4 ]
机构
[1] Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomed & Nanosafety, Beijing 100190, Peoples R China
[2] CAS Ctr Excellence Nanosci, Natl Ctr Nanosci & Technol China, Beijing 100190, Peoples R China
[3] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China
[4] GBA Natl Inst Nanotechnol Innovat, Guangzhou 510700, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金; 国家重点研发计划;
关键词
X-RAY MICROSCOPY; FLUORESCENCE MICROSCOPY; TOMOGRAPHY; CELLS; NANOPARTICLES; MICROTOMOGRAPHY; TRANSMISSION; CLEARANCE; DIAGNOSIS; CHEMISTRY;
D O I
10.1021/acscentsci.2c00680
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Exploration of the biological behavior and fate of nanoparticles, as affected by the nanomaterial-biology (nano-bio) interaction, has become progressively critical for guiding the rational design and optimization of nanomedicines to minimize adverse effects, support clinical translation, and aid in evaluation by regulatory agencies. Because of the complexity of the biological environment and the dynamic variations in the bioactivity of nanomedicines, insitu, label-free analysis of the transport and transformation of nanomedicines has remained a challenge. Recent improvements in optics, detectors, and light sources have allowed the expansion of advanced light source (ALS) analytical technologies to dig into the underexplored behavior and fate of nanomedicines in vivo. It is increasingly important to further develop ALS-based analytical technologies with higher spatial and temporal resolution, multimodal data fusion, and intelligent prediction abilities to fully unlock the potential of nanomedicines. In this Outlook, we focus on several selected ALS analytical technologies, including imaging and spectroscopy, and provide an overview of the emerging opportunities for their applications in the exploration of the biological behavior and fate of nanomedicines. We also discuss the challenges and limitations faced by current approaches and tools and the expectations for the future development of advanced light sources and technologies. Improved ALS imaging and spectroscopy techniques will accelerate a profound understanding of the biological behavior of new nanomedicines. Such advancements are expected to inspire new insights into nanomedicine research and promote the development of ALS capabilities and methods more suitable for nanomedicine evaluation with the goal of clinical translation.
引用
收藏
页码:1063 / 1080
页数:18
相关论文
共 5 条
  • [1] Tissue Specific Fate of Nanomaterials by Advanced Analytical Imaging Techniques - A Review
    Graham, Uschi M.
    Dozier, Alan K.
    Oberdorster, Gunter
    Yokel, Robert A.
    Molina, Ramon
    Brain, Joseph D.
    Pinto, Jayant M.
    Weuve, Jennifer
    Bennett, David A.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (05) : 1145 - 1162
  • [2] Biological soft X-ray tomography on beamline 2.1 at the Advanced Light Source
    Le Gros, Mark A.
    McDermott, Gerry
    Cinquin, Bertrand P.
    Smith, Elizabeth A.
    Do, Myan
    Chao, Weilun L.
    Naulleau, Patrick P.
    Larabell, Carolyn A.
    JOURNAL OF SYNCHROTRON RADIATION, 2014, 21 : 1370 - 1377
  • [3] Nano-Bio Interactions: Exploring the Biological Behavior and the Fate of Lipid-Based Gene Delivery Systems
    Kimura, Seigo
    Harashima, Hideyoshi
    BIODRUGS, 2024, 38 (02) : 259 - 273
  • [4] In situ Analysis of the Fate and Behavior of Inorganic Nanomaterials in Biological Systems by Synchrotron Radiation X-ray Probe Techniques
    Zhu, Shuang
    Wang, Yaling
    Chen, Chunying
    CURRENT ANALYTICAL CHEMISTRY, 2022, 18 (06) : 723 - 738
  • [5] Investigating the Anti-Wear Behavior of Polyalphaolefin Oil with Methyl Silicon Resin Using Advanced Analytical Techniques
    Wang, Haiyang
    He, Zhongyi
    Xiong, Liping
    Qian, Liang
    Li, Lili
    Long, Qiyang
    LUBRICANTS, 2024, 12 (12)